History
  • No items yet
midpage
Monsanto Co. v. Bayer Bioscience NV
514 F.3d 1229
Fed. Cir.
2008
Check Treatment
Docket

Monsanto v. Bayer Bioscience

Appeal No. 2007-1109

United States Court of Appeals for the Federal Circuit

April 4, 2008

Precedential Opinion, Decided: January 25, 2008

ERRATA

On page 3, footnote 5: add “, of the Bt2 class of toxins.” at the end of the last sentence.

On page 8, line 6: insert “, including the sequence specific claims,” after “rejected all claims”

On page 8, line 24: insert “canceled its broadest claims and” after “In reply to the office action, Bayer”

On page 9, line 25: insert “3.4 kB” after “truncated a”

On page 9, line 25: insert new footnote 9 after “Bt toxin gene“: “kB, or kilobases, is a unit of length equal to 1000 base pairs of DNA. The Bt2 toxin gene Bayer was using was also approximately 3.4 kB.”

On page 14, footnote 11: replace “at the time, Bayer was arguing that” with “despite having canceled the broader claims ‘solely to expedite the prosecution of th[e] application, and not to acquiesce to the rejection,’ at the time Bayer distinguished Barnes, it was continuing to argue that”

On page 16, line 11: replace “and thus one that encoded” with “which for the Bt2 gene would encode”

On page 16, line 11: insert “smaller than 67 kD and” after “a size”

On page 16, footnote 14: delete footnote

Case Details

Case Name: Monsanto Co. v. Bayer Bioscience NV
Court Name: Court of Appeals for the Federal Circuit
Date Published: Apr 4, 2008
Citation: 514 F.3d 1229
Docket Number: 2007-1109
Court Abbreviation: Fed. Cir.
AI-generated responses must be verified and are not legal advice.